Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Genet Med ; 19(6): 652-658, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-27735925

RESUMO

PURPOSE: The overall published experience with pediatric type 1 Gaucher disease (GD1) has been based on ascertainment through clinical presentation of the disease. We describe the longitudinal follow-up in a presymptomatic pediatric cohort. METHODS: The cohort includes children diagnosed with GD1, either prenatally or postnatally by molecular genetic testing, and followed for clinical care at our center from 1998 to 2016. All patients' parents were GBA mutation carriers identified through carrier screening programs. Longitudinal clinical, laboratory, and imaging data were obtained through chart review. RESULTS: Thirty-eight patients aged 1-18 years (mean at last visit 6.9 ± 4.1 years) were followed, including 32 p.N409S homozygotes and 6 p.N409S/p.R535H compound heterozygotes. At the last evaluation, a minority had hematological (5%), bone (15%), or linear growth (19%) issues. Only 12% had splenomegaly and 74% had moderate hepatomegaly. Chitotriosidase activity varied widely (6-5,640 nmol/hour/ml) and generally increased with age. Pediatric Gaucher severity scores (GSS) remained stable and within the mild-disease range for most (95%). Treatment for progressive disease during this period was recommended for four children. CONCLUSION: Most children with the p.N409S/p.N409S and p.N409S/p.R535H GD1 genotypes have minimal disease manifestations and progression during childhood and can be monitored using limited assessments. Those with other mutations may require additional monitoring. These data are valuable for newborn screening and counseling.Genet Med advance online publication 13 October 2016.


Assuntos
Doença de Gaucher/diagnóstico , Triagem de Portadores Genéticos , Adolescente , Criança , Pré-Escolar , Estudos de Coortes , Feminino , Doença de Gaucher/enzimologia , Doença de Gaucher/genética , Doença de Gaucher/fisiopatologia , Aconselhamento Genético , Hexosaminidases/metabolismo , Humanos , Lactente , Estudos Longitudinais , Masculino , Pais , Índice de Gravidade de Doença
2.
ScientificWorldJournal ; 2013: 470174, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24348161

RESUMO

The present paper analytically discusses the phenomenon of fingering in double phase flow through homogenous porous media by using variational iteration method. Fingering phenomenon is a physical phenomenon which occurs when a fluid contained in a porous medium is displaced by another of lesser viscosity which frequently occurred in problems of petroleum technology. In the current investigation a mathematical model is presented for the fingering phenomenon under certain simplified assumptions. An approximate analytical solution of the governing nonlinear partial differential equation is obtained using variational iteration method with the use of Mathematica software.


Assuntos
Modelos Teóricos , Física
3.
Am J Med Genet A ; 158A(5): 1170-7, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22488896

RESUMO

Autism spectrum disorders (ASDs) are phenotypically complex developmental neuropsychiatric disorders affecting approximately 0.6% of the population. About 30-70% of affected children are also considered to have intellectual disability (ID). The underlying genetic causes of ASDs are diverse with a defined etiology in 16-20%. Array comparative genomic hybridization (aCGH) has proven useful in identifying sub-microscopic chromosome aberrations in a subset of patients, some of which have been shown to be recurrent. One such aberration is the 1.4 Mb microdeletion at chromosome 17q12, which has been reported to be associated with renal disease, growth restriction, diabetes, cognitive impairment, seizures, and in some cases an ASD. Patients with the reciprocal chromosome 17q12 microduplication typically have also been identified with ID and in some cases seizures and behavioral abnormalities. Here we report a patient with a de novo, 1.4 Mb microduplication diagnosed with significant ID involving complex deficits and autism. To our knowledge, this is the first report of a patient with the 17q12 microduplication and a complex ASD phenotype.


Assuntos
Transtornos Globais do Desenvolvimento Infantil/genética , Deleção Cromossômica , Duplicação Cromossômica , Cromossomos Humanos Par 17 , Pré-Escolar , Hibridização Genômica Comparativa , Humanos , Deficiência Intelectual/genética , Masculino , Pais
4.
Eur J Med Genet ; 56(11): 619-23, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24056159

RESUMO

Steroidogenic factor 1 (SF1) is a nuclear receptor encoded by the NR5A1 gene. SF1 affects both sexual and adrenal development through the regulation of target gene expression. Genotypic male and female SF1 knockout mice have adrenal and gonadal agenesis with persistent Müllerian structures and early lethality. There have been several reports of NR5A1 mutations in individuals with 46,XY complete gonadal dysgenesis (CGD) or other disorders of sex development (DSD) with or without an adrenal phenotype. To date microdeletions involving NR5A1 have been reported in only two patients with DSDs. We report a novel microdeletion encompassing NR5A1 in a patient with 46,XY DSD and developmental delay. The phenotypically female patient initially presented with mild developmental delay and dysmorphisms. Chromosome analysis revealed a 46,XY karyotype. A 1.54 Mb microdeletion of chromosome 9q33.3 including NR5A1 was detected by array CGH and confirmed by FISH. Normal maternal FISH results indicated that this was most likely a de novo event. Since most NR5A1 mutations have been ascertained through gonadal or adrenal abnormalities, the additional findings of developmental delay and minor facial dysmorphisms are possibly related to haploinsufficiency of other genes within the 1.54 Mb deleted region. This report further confirms the role of NR5A1 deletions in 46,XY DSD and reinforces the utility of aCGH in the work up of DSDs of unclear etiology.


Assuntos
Anormalidades Múltiplas/genética , Cromossomos Humanos Par 9/genética , Deficiências do Desenvolvimento/genética , Transtorno 46,XY do Desenvolvimento Sexual/genética , Deleção de Genes , Fator Esteroidogênico 1/genética , Anormalidades Múltiplas/diagnóstico , Criança , Deficiências do Desenvolvimento/diagnóstico , Transtorno 46,XY do Desenvolvimento Sexual/diagnóstico , Feminino , Humanos , Cariótipo , Síndrome
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA